Results 81 to 90 of about 84,964 (303)

Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity

Acta Médica Portuguesa, 2020
Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin ...
Alexandre Camões- Barbosa, Inês Mendes Ribeiro, Luisa Medeiros   +2 more
doaj   +1 more source

Double Sandwich ELISA Modified Method for the Detection of Clostridium Botulinum Type E [PDF]

Journal of Fasa University of Medical Sciences, 2013
Background & Objective: A very small amount of botulinum toxin can cause death and on the other hand, there is no cure for its poison other than antitoxin.
Mohammad Ebrahim minaei, Mojtaba Saadati
doaj   +1 more source

Cross-linguistic study of vocal pathology: perceptual features of spasmodic dysphonia in French-speaking subjects [PDF]

, 2003
Clinical characterisation of Spasmodic Dysphonia of the adductor type (SD) in French speakers by Klap and colleagues (1993) appears to differ from that of SD in English. This perceptual analysis aims to describe the phonetic features of French SD.
BRIN M. F., CRYSTAL D. A., DARLEY F., DELATTRE P., DENES P. B., KLAP P., LANGEN DE, LAVER J., MALECOT A., MARJORIE PERLMAN LORCH, RENATA WHURR, WHURR R., WHURR R.   +12 more
core   +1 more source

Resolution of Levodopa/Dopa‐Decarboxylase Inhibitor—Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Microscopic colitis (MC) typically presents with chronic, non‐bloody watery diarrhea. Diagnosis requires endoscopy with colonic mucosal biopsies. The etiology is multifactorial, with several medications implicated, although only a few cases have been attributed to oral levodopa/dopa‐decarboxylase inhibitor (LDDCI) therapy.
Romana Hintner, Franziska Eberhardt, Manuela Kofler, Andreas Eigentler, Atbin Djamshidian, Florian Krismer, Anton Hittmair, Heinz Zoller, Valentina Ellinger, Beatrice Heim, Klaus Seppi   +10 more
wiley   +1 more source

Precisely specifying which botulinum toxin products are used for aesthetic treatments is essential

Journal of Oral Biology and Craniofacial Research, 2022
Andy Pickett
doaj   +1 more source

The impact of hyperhidrosis on patients' daily life and quality of life : A qualitative investigation [PDF]

, 2017
Background: An understanding of the daily life impacts of hyperhidrosis and how patients deal with them, based on qualitative research, is lacking.
A. Schouveller, B. Mueller, B. Stacey, C Golics, C Kerr, C Muller, C Pope, CS Cina, D Innocenzi, DL Patrick, DR Strutton, EJ Park, GA Bowen, H Beltraminelli, H Hamm, J Schmidt, J. Halford, JW Creswell, M Amini, M Augustin, M Lupin, M.S. Salek, MK Naumann, MM Chren, N Solish, O Young, P Kamudoni, P. Kamudoni, RA Tupker, SO Lima, SR Tan, T Fujimoto, V Braun, WO Kim, Y Hongbo   +34 more
core   +2 more sources

MDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel Insights

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Hereditary spastic paraplegia (HSP) is a neurodegenerative disorder characterized by progressive spasticity and lower limb weakness. The most common forms of autosomal dominant HSP are caused by pathogenic variants in SPAST (SPG4 or HSP‐SPAST), ATL1 (SPG3A or HSP‐ATL1), and REEP1 (SPG31 or HSP‐REEP1).
Ce Kang, Rajasumi Rajalingam, Zachary Walls, Jana Huang, Christine Sun, Laura I. Rudaks, Dennis Yeow, Ashar Rasheed, Jenny W. Zhang, Moath Hamed, Marianthi Breza, Susen Schaake, Chetan Vekhande, Jason Massa, Robyn E. Massa, Aakash Shetty, Carolyn M. Sue, Franca Cambi, Oksana Suchowersky, Franca Vulinovic, Sonja Petkovic, Christine Klein, Katja Lohmann, Connie Marras, Kishore R. Kumar   +24 more
wiley   +1 more source

The Pain in Dystonia Scale (PIDS)—Validation in Craniofacial and Upper Limb Dystonia

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Pain is one of the most disabling non‐motor symptoms in adult‐onset isolated dystonia (AOID). The Pain in Dystonia Scale (PIDS) was developed and validated in cervical dystonia. Its applicability to other focal subtypes remains unknown.
Veronica Bruno, Vittorio Velucci, Beatrice Achen, Marcello Mario Mascia, Antonella Muroni, Daniele Belvisi, Francesco Marchet, Laura Avanzino, Francesca Di Biasio, Roberto Erro, Cristiano Sorrentino, Lucio Marinelli, Flavio Villani, Antonio Pisani, Francesca Valentino, Angelo Fabio Gigante, Anna Castagna, Francesco Bono, Giovanni Cossu, Carlo Alberto Artusi, Carmen Terranova, Martina Petracca, Nicola Tambasco, Giovanni Defazio, Davide Martino   +24 more
wiley   +1 more source

The role of botulinum toxin in the treatment of diseases beyond aesthetics: migraine, hyperhidrosis and bruxism - literature review

Quality in Sport
In the 19th century, botulinum toxin was recognized solely as a poison. Subsequent research led to its medical applications, and today, it is predominantly utilized in aesthetic medicine.
Karolina Oskroba, Maciej Sokołowski, Estera Graczyk, Joanna Kryślak, Katarzyna Skibicka, Adam Solarz, Szymon Szabelski, Oliwia Cwalina, Jakub Filip Turcza   +8 more
doaj   +1 more source

Safety and Pharmacokinetics of a Four Monoclonal Antibody Combination Against Botulinum C and D Neurotoxins. [PDF]

, 2019
Botulism is caused by botulinum neurotoxin (BoNT), the most poisonous substance known. BoNTs are also classified as Tier 1 biothreat agents due to their high potency and lethality.
Cobb, Ronald R, Conrad, Fraser, Espinoza, Yero, Garcia-Rodriguez, Consuelo, Kimbler, Angie, Kraus, Carl N, Marks, James D, Martinez, Zachary, Pham, Khanh, Riling, Kathryn, Snow, Doris M, Tomic, Milan T, Wong, David   +12 more
core